Good Samaritan Society - Park River | |
301 South County Road 12b, Park River, North Dakota 58270 | |
(701) 284-7115 | |
Name | Good Samaritan Society - Park River |
---|---|
Location | 301 South County Road 12b, Park River, North Dakota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 54 |
Occupancy Rate | 79.26% |
Medicare ID (CCN) | 355089 |
Legal Business Name | The Evangelical Lutheran Good Samaritan Society |
Ownership Type | Non Profit - Corporation |
NPI Number | 1487635496 |
Organization Name | THE EVANGELICAL LUTHERAN GOOD SAMARITAN SOCIETY |
Doing Business As | GOOD SAMARITAN SOCIETY - PARK RIVER |
Address | 301 County Road 12b, Park River, ND 58270 |
Phone Number | 701-284-7115 |
News Archive
A commentary published online October 23 in the Journal of the National Cancer Institute summarizes a set of critical decision points in cancer biomarker and drug development. The points, which emerged from a workshop, include developing a clear understanding of the biology of the target and its interaction with the drug and the factors affecting the performance of the biomarker assay.
Two leading medical organizations say that using a Human papillomavirus (HPV) test alone for cervical cancer screening is an effective alternative to the current recommendation for screening with either cytology (the Pap test) alone or co-testing with cytology and HPV testing.
"The Microbicide Trials Network (MTN), which is funded by the U.S. National Institutes of Health, on Wednesday announced that it decided to stop one arm of a study involving more than 5,000 women in South Africa, Zimbabwe, and Uganda" after "an interim review of the ongoing trial by an independent monitoring board found that the drug tenofovir when used as pre-exposure prophylaxis (PrEP) had less effect in protecting women than anticipated," Science Magazine's "Science Insider" blog reports.
With the aid of X-ray crystallography, researchers at the University of Michigan have revealed the structures of two closely related enzymes that play essential roles in the body's ability to metabolize excess lipids, including cholesterol.
› Verified 1 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
A commentary published online October 23 in the Journal of the National Cancer Institute summarizes a set of critical decision points in cancer biomarker and drug development. The points, which emerged from a workshop, include developing a clear understanding of the biology of the target and its interaction with the drug and the factors affecting the performance of the biomarker assay.
Two leading medical organizations say that using a Human papillomavirus (HPV) test alone for cervical cancer screening is an effective alternative to the current recommendation for screening with either cytology (the Pap test) alone or co-testing with cytology and HPV testing.
"The Microbicide Trials Network (MTN), which is funded by the U.S. National Institutes of Health, on Wednesday announced that it decided to stop one arm of a study involving more than 5,000 women in South Africa, Zimbabwe, and Uganda" after "an interim review of the ongoing trial by an independent monitoring board found that the drug tenofovir when used as pre-exposure prophylaxis (PrEP) had less effect in protecting women than anticipated," Science Magazine's "Science Insider" blog reports.
With the aid of X-ray crystallography, researchers at the University of Michigan have revealed the structures of two closely related enzymes that play essential roles in the body's ability to metabolize excess lipids, including cholesterol.
› Verified 1 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 16.67 | 14.46 |
Percentage of long-stay residents who lose too much weight | 10.53 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 49.28 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.74 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 8.86 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 3.73 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.15 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 8.67 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.44 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 22.09 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 17.06 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 4.55 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.95 | 95.98 |